Single-Fraction Stereotactic Body Radiotherapy for Localized Prostate Cancer

Дата публикации: 18-06-2026 00:00:00

This nonrandomized clinical trial evaluates the efficacy and tolerance of single-fraction stereotactic body radiotherapy in men with localized prostate cancer.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Race, Secondary Treatment, and Survival in Localized Prostate Cancer	0	5.24	21-07-2026
2	Medically Assisted Reproduction and Hormone-Related Cancers	0	5	13-07-2026
3	Bispecific Antibody Ivonescimab Added to Chemotherapy in EGFR -Variant Non–Small Cell Lung Cancer	0	10	28-07-2026
4	Neoadjuvant Paclitaxel, Trastuzumab, and Pertuzumab for Stage II to III, ERBB2 -Positive Breast Cancer	0	7	25-06-2026
5	Outcomes in Patients With Recurrent Ovarian Cancer and Exceptional Response to PARP Inhibitors	0	7	25-06-2026
6	Cardiac Risk After Heart-Sparing Breast Radiotherapy	0	5	02-07-2026
7	Study helps predict how long it will take for testosterone to return to normal after prostate cancer treatment	5	7	25-09-2024
8	Neuer Radiohybrid-Ansatz verbindet PET und SPECT für passgenauere Prostatakrebs-Therapie	2	7	14-07-2026
9	Study solves testosterone's paradoxical effects in prostate cancer	0	8	04-09-2024
10	Gefurulimab and Generalized Myasthenia Gravis	0	10.42	27-07-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 5. Источник: jamanetwork.com.